DLX5 and non-small cell lung carcinoma: In a study of human non-small cell lung cancer (NSCLC), DLX5 was determined to be activated by KDM4A-mediated demethylation, and in turn, DLX5 induced the expression of MYC and β-catenin, thereby, promoting proliferation and metastasis [85].